| Dendritic cell subsets in health and disease H Ueno, E Klechevsky, R Morita, C Aspord, T Cao, T Matsui, T Di Pucchio, ... Immunological reviews 219 (1), 118-142, 2007 | 654 | 2007 |
| Breast cancer instructs dendritic cells to prime interleukin 13–secreting CD4+ T cells that facilitate tumor development C Aspord, A Pedroza-Gonzalez, M Gallegos, S Tindle, EC Burton, D Su, ... The Journal of experimental medicine 204 (5), 1037-1047, 2007 | 401 | 2007 |
| Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation A Pedroza-Gonzalez, K Xu, TC Wu, C Aspord, S Tindle, F Marches, ... Journal of Experimental Medicine 208 (3), 479-490, 2011 | 284 | 2011 |
| X-Chromosome complement and estrogen receptor signaling independently contribute to the enhanced TLR7-mediated IFN-α production of plasmacytoid dendritic cells from women S Laffont, N Rouquié, P Azar, C Seillet, J Plumas, C Aspord, JC Guéry The Journal of Immunology 193 (11), 5444-5452, 2014 | 183 | 2014 |
| Plasmacytoid dendritic cells support melanoma progression by promoting Th2 and regulatory immunity through OX40L and ICOSL C Aspord, MT Leccia, J Charles, J Plumas Cancer immunology research 1 (6), 402-415, 2013 | 174 | 2013 |
| Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection J Martinet, T Dufeu–Duchesne, JB Costa, S Larrat, A Marlu, V Leroy, ... Gastroenterology 143 (6), 1586-1596. e8, 2012 | 150 | 2012 |
| Characterization of circulating dendritic cells in melanoma: role of CCR6 in plasmacytoid dendritic cell recruitment to the tumor J Charles, J Di Domizio, D Salameire, N Bendriss-Vermare, C Aspord, ... Journal of Investigative Dermatology 130 (6), 1646-1656, 2010 | 94 | 2010 |
| Predictive factors for response to PD-1/PD-L1 checkpoint inhibition in the field of hepatocellular carcinoma: current status and challenges Z Macek Jilkova, C Aspord, T Decaens Cancers 11 (10), 1554, 2019 | 93 | 2019 |
| Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice C Aspord, C Thivolet Clinical & Experimental Immunology 130 (2), 204-211, 2002 | 91 | 2002 |
| Imiquimod inhibits melanoma development by promoting pDC cytotoxic functions and impeding tumor vascularization C Aspord, L Tramcourt, C Leloup, JP Molens, MT Leccia, J Charles, ... Journal of investigative dermatology 134 (10), 2551-2561, 2014 | 72 | 2014 |
| Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer J Charles, L Chaperot, D Salameire, J Di Domizio, C Aspord, R Gressin, ... European Journal of Dermatology: EJD 20 (1), 16, 2010 | 72 | 2010 |
| Immunotherapy via dendritic cells AK Palucka, B Laupeze, C Aspord, H Saito, G Jego, J Fay, S Paczesny, ... Mechanisms of Lymphocyte Activation and Immune Regulation X: Innate Immunity …, 2005 | 72 | 2005 |
| A novel cancer vaccine strategy based on HLA-A* 0201 matched allogeneic plasmacytoid dendritic cells C Aspord, J Charles, MT Leccia, D Laurin, MJ Richard, L Chaperot, ... PloS one 5 (5), e10458, 2010 | 69 | 2010 |
| T-Cell Homing to the Pancreas in Autoimmune Mouse Models of Diabetes: In Vivo MR Imaging1 C Billotey, C Aspord, O Beuf, E Piaggio, F Gazeau, MF Janier, C Thivolet Radiology 236 (2), 579-587, 2005 | 56 | 2005 |
| Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection J Martinet, V Leroy, T Dufeu‐Duchesne, S Larrat, MJ Richard, F Zoulim, ... Hepatology 56 (5), 1706-1718, 2012 | 48 | 2012 |
| An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial J Charles, L Chaperot, D Hannani, J Bruder Costa, I Templier, S Trabelsi, ... Oncoimmunology 9 (1), 1738812, 2020 | 45 | 2020 |
| Immunologic features of patients with advanced hepatocellular carcinoma before and during sorafenib or anti-programmed death-1/programmed death-L1 treatment ZM Jilkova, C Aspord, K Kurma, A Granon, C Sengel, N Sturm, PN Marche, ... Clinical and translational gastroenterology 10 (7), e00058, 2019 | 45 | 2019 |
| HLA-A* 0201+ plasmacytoid dendritic cells provide a cell-based immunotherapy for melanoma patients C Aspord, MT Leccia, D Salameire, D Laurin, L Chaperot, J Charles, ... Journal of investigative dermatology 132 (10), 2395-2406, 2012 | 45 | 2012 |
| Early events in islets and pancreatic lymph nodes in autoimmune diabetes C Aspord, S Rome, C Thivolet Journal of autoimmunity 23 (1), 27-35, 2004 | 43 | 2004 |
| Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses R Ghinnagow, J De Meester, LJ Cruz, C Aspord, S Corgnac, ... Oncoimmunology 6 (9), e1339855, 2017 | 41 | 2017 |
